Title: Consequences, Opportunities and Challenges of Modern Biotechnology for Europe
Authors: BOCK ANNE-KATRINPAPATRYFON ILIASZIKA EleniWOLF OLIVERGOMEZ BARBERO MANUELSTEIN Alexander Jivraj
Publisher: European Commission
Publication Year: 2007
JRC N°: JRC36951
ISBN: 978-92-79-05362-7
ISSN: 1018-5593
Other Identifiers: EUR 22728 EN
OPOCE LF-NA-22728-EN-C
URI: http://publications.jrc.ec.europa.eu/repository/handle/JRC36951
Type: JRC Reference Reports
Abstract: Modern biotechnology products and processes are an integral part of the EU economy, mainly in manufacturing, including pharmaceuticals, agro-food and healthcare. While some products are not recognizable to the broader public (e.g. the use of genetic markers in livestock breeding), others are used on a daily basis (detergents with enzymes, recombinant insulin) or have become subject of public discussion (e.g. genetically modified crops). Modern bioetchnology contributes significantly to the achievement of major EU polciy objectives.
JRC Institute:Institute for Prospective Technological Studies

Files in This Item:
File Description SizeFormat 
eur22728en.pdf5.6 MBAdobe PDFView/Open


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.